Your browser doesn't support javascript.
loading
Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.
Fundytus, Adam; Sengar, Manju; Lombe, Dorothy; Hopman, Wilma; Jalink, Matthew; Gyawali, Bishal; Trapani, Dario; Roitberg, Felipe; De Vries, Elisabeth G E; Moja, Lorenzo; Ilbawi, André; Sullivan, Richard; Booth, Christopher M.
Afiliação
  • Fundytus A; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, ON, Canada; Departments of Oncology, Queen's University, Kingston, ON, Canada.
  • Sengar M; Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.
  • Lombe D; Cancer Diseases Hospital, Lusaka, Zambia.
  • Hopman W; Public Health Sciences, Queen's University, Kingston, ON, Canada.
  • Jalink M; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, ON, Canada.
  • Gyawali B; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, ON, Canada; Departments of Oncology, Queen's University, Kingston, ON, Canada; Public Health Sciences, Queen's University, Kingston, ON, Canada.
  • Trapani D; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.
  • Roitberg F; Department of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland.
  • De Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • Moja L; Department of Health Products Policy and Standards, World Health Organization, Geneva, Switzerland.
  • Ilbawi A; Department of Health Products Policy and Standards, World Health Organization, Geneva, Switzerland.
  • Sullivan R; Institute of Cancer Policy, King's College London, London, UK.
  • Booth CM; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, ON, Canada; Departments of Oncology, Queen's University, Kingston, ON, Canada; Public Health Sciences, Queen's University, Kingston, ON, Canada. Electronic address: booth@queensu.ca.
Lancet Oncol ; 22(10): 1367-1377, 2021 10.
Article em En | MEDLINE | ID: mdl-34560006
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Saúde Global / Medicamentos Essenciais / Disparidades em Assistência à Saúde / Oncologistas / Acessibilidade aos Serviços de Saúde / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Saúde Global / Medicamentos Essenciais / Disparidades em Assistência à Saúde / Oncologistas / Acessibilidade aos Serviços de Saúde / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá País de publicação: Reino Unido